Drug Shortage Report for ROTATEQ

Last updated on 2021-04-07 History
Report ID 134639
Drug Identification Number 02284413
Brand name ROTATEQ
Common or Proper name rotavirus vaccine, live, oral, pentavalent oral solution
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE P1
Strength(s) 2210000UNIT 2840000UNIT 2220000UNIT 2040000UNIT 2290000UNIT
Dosage form(s) SOLUTION
Route of administration ORAL ORAL
Packaging size 10 X 1 DOSE VIAL
ATC code J07BH
ATC description VIRAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2021-04-09
Actual start date
Estimated end date 2021-04-16
Actual end date 2021-04-07
Shortage status Avoided shortage
Updated date 2021-04-07
Company comments Format ROTATEQ 2ML 1DOSE TUBE CAN remains available.
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-04-07 English Compare
v6 2021-03-31 English Compare
v5 2021-03-22 English Compare
v4 2021-02-24 English Compare
v3 2021-02-24 French Compare
v2 2021-02-24 English Compare
v1 2021-02-24 English Compare